AGP Executive Report
Last update: 12 hours agoClinical Research & Eye Health: EyePoint released topline Phase 3 results for DURAVYU™ (LUGANO) in wet AMD, highlighting a 42% reduction in treatment burden and high supplement-free rates, with the second pivotal trial (LUCIA) expected in Q4 2026. Public Health & Safety (Drugs): Macau’s Legislative Assembly unanimously approved urgent amendments adding 13 substances to the forbidden drugs list, including analogues of “space oil,” with a focus on risks linked to e-cigarettes/vapes. Food Safety: McDonald’s Macau temporarily suspended its “Ebi Burger” series after Taiwan reported shrimp patties exceeding synthetic antibiotic standards; Macau says local batches differ but paused sales as a precaution. Exercise & Heart Risk: A Macao Polytechnic University-linked study found 560–610 minutes/week of moderate-to-vigorous activity is tied to over 30% lower heart attack and stroke risk. Local Health Policy & Governance: Macau’s government consultation on a new legal regime for associations stresses national security and “healthy, sustainable” development, including how associations link with mainland/Hong Kong and beyond. Community Wellness (Youth): MGM’s Golden Lion Summer Camp in Hengqin drew a record 200+ students (14–18), mixing team activities with a nutrition science visit at By-Health’s Nutrition Explore Center. Health-Adjacent Business: IPIM reported 194 new investment projects in H1 2026, with big health/biomedicine among the fastest-growing “1+4” sectors. Injury Update: A 73-year-old woman died after being struck by a coach near the Barrier Gate; she was taken to Conde de São Januário Hospital Centre but later pronounced dead.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.